rg-7599
mAbexperimentalADC
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 14, 2011 (NCT01363947)
Timeline
Indications
Mechanism of action
- Sodium-dependent phosphate transport protein 2BImmunity, passive
SLC34A2 immunity, passive
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
- Payload
- Monomethylauristatin E
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109280 ↗
Also known as
- dnib0600a
- rg-7599
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01991210 | Phase 2 | Feb 1, 2014 | Genentech |
| NCT01995188 | Phase 1 | Dec 1, 2013 | Genentech |
| NCT01363947 | Phase 1 | Jun 14, 2011 | Genentech |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Genentech | For profit | 3 | 3 | 2 | 2011 |
1 organizations
Page 1 / 1